The American Society of Clinical Oncology’s Annual meeting was held May 29-June 2, 2015 in Chicago. The meeting features an extensive program of presentations on cancer therapies. Data for numerous antibodies, including avelumab, bavituximab, ensituximab, HuMax-Axl-ADC, OBT357/MEN1112, MEDI4736, MEDI0680, PF-05082566, NI-1701, SEA-CD40, REGN1979, and the CEA-directed BiTE MEDI-565/AMG 211 were made available in abstracts. The meeting abstracts can be accessed here.